Morgan Stanley, Goldman Sachs, UBS all recommend buying gold after latest Trump tariffs — Positive
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — July 15, 2025Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
Can GameStop Overcome Declines in Hardware & Software Sales? — Neutral
GME Zacks Investment Research — July 15, 2025GME's Q1 sales slide 16.9% as hardware and software declines highlight its fading physical retail focus.
David Sacks on Nvidia Chips to China, US Tech Stack — Positive
NVDA Bloomberg Technology — July 15, 2025White House AI and Crypto Czar David Sacks discusses the easing of curbs on the sale of Nvidia and Advanced Micro Devices chips to China, boosting US tech exports in the global market, addressing security concerns around chip technology, and energy investment to support AI. -------- Like this video?
The Colorado-based gold miner is beginning the search for a permanent chief financial officer.
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PEPG — Neutral
PEPG GlobeNewsWire — July 15, 2025NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, both dates inclusive (the “Class Period”), of the important August 8, 2025 lead plaintiff deadline.
Can TGT's AI Strategy Drive a Faster & Smarter Retail Transformation? — Positive
TGT Zacks Investment Research — July 15, 2025Target bets on AI to cut inefficiencies, boost execution speed and stay ahead of shifting consumer trends.
Cintas Gears Up to Report Q4 Earnings: What's in the Offing? — Positive
CTAS Zacks Investment Research — July 15, 2025CTAS' Q4 results are likely to reflect solid segment growth and M&A synergies, though rising SG&A costs are likely to have weighed on margins.
Marex Group PLC (MRX) Upgraded to Buy: Here's Why — Positive
MRX Zacks Investment Research — July 15, 2025Marex Group PLC (MRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Are You Looking for a Top Momentum Pick? Why Evercore (EVR) is a Great Choice — Positive
EVR Zacks Investment Research — July 15, 2025Does Evercore (EVR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zoom (ZM) Upgraded to Buy: Here's What You Should Know — Positive
ZM Zacks Investment Research — July 15, 2025Zoom (ZM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why Ducommun (DCO) is a Great Momentum Stock to Buy — Positive
DCO Zacks Investment Research — July 15, 2025Does Ducommun (DCO) have what it takes to be a top stock pick for momentum investors? Let's find out.
ACNB (ACNB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Robinhood Markets, Inc. (HOOD) Is Up 4.17% in One Week: What You Should Know — Positive
HOOD Zacks Investment Research — July 15, 2025Does Robinhood Markets, Inc. (HOOD) have what it takes to be a top stock pick for momentum investors? Let's find out.
Rapt Therapeutics (RAPT) Upgraded to Strong Buy: Here's Why — Positive
RAPT Zacks Investment Research — July 15, 2025Rapt Therapeutics (RAPT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ARS Pharmaceuticals, Inc. (SPRY) is a Great Momentum Stock: Should You Buy? — Positive
SPRY Zacks Investment Research — July 15, 2025Does ARS Pharmaceuticals, Inc. (SPRY) have what it takes to be a top stock pick for momentum investors? Let's find out.
All You Need to Know About Cellectar Biosciences (CLRB) Rating Upgrade to Buy — Positive
CLRB Zacks Investment Research — July 15, 2025Cellectar Biosciences (CLRB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
SoFi Technologies, Inc. (SOFI) Is Up 14.16% in One Week: What You Should Know — Positive
SOFI Zacks Investment Research — July 15, 2025Does SoFi Technologies, Inc. (SOFI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Aldeyra Therapeutics (ALDX) Upgraded to Strong Buy: What Does It Mean for the Stock? — Positive
ALDX Zacks Investment Research — July 15, 2025Aldeyra Therapeutics (ALDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
WNS (Holdings) Limited (WNS) is a Great Momentum Stock: Should You Buy? — Positive
WNS Zacks Investment Research — July 15, 2025Does WNS (Holdings) Limited (WNS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Amgen (AMGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
